nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroxyaluminium—VDAC3—hair follicle—melanoma	0.0894	0.136	CbGeAlD
Dihydroxyaluminium—VDAC1—hair follicle—melanoma	0.085	0.13	CbGeAlD
Dihydroxyaluminium—VDAC2—eye—melanoma	0.0536	0.0816	CbGeAlD
Dihydroxyaluminium—VDAC2—skin of body—melanoma	0.0466	0.071	CbGeAlD
Dihydroxyaluminium—VDAC3—eye—melanoma	0.0446	0.068	CbGeAlD
Dihydroxyaluminium—VDAC1—eye—melanoma	0.0424	0.0646	CbGeAlD
Dihydroxyaluminium—VDAC3—skin of body—melanoma	0.0388	0.0591	CbGeAlD
Dihydroxyaluminium—VDAC1—skin of body—melanoma	0.0369	0.0562	CbGeAlD
Dihydroxyaluminium—VDAC3—mammalian vulva—melanoma	0.0354	0.0539	CbGeAlD
Dihydroxyaluminium—VDAC1—mammalian vulva—melanoma	0.0337	0.0513	CbGeAlD
Dihydroxyaluminium—VDAC2—head—melanoma	0.0304	0.0463	CbGeAlD
Dihydroxyaluminium—VDAC3—head—melanoma	0.0253	0.0386	CbGeAlD
Dihydroxyaluminium—VDAC1—head—melanoma	0.0241	0.0367	CbGeAlD
Dihydroxyaluminium—VDAC2—lymph node—melanoma	0.0213	0.0324	CbGeAlD
Dihydroxyaluminium—VDAC3—lymph node—melanoma	0.0177	0.027	CbGeAlD
Dihydroxyaluminium—VDAC1—lymph node—melanoma	0.0169	0.0257	CbGeAlD
Dihydroxyaluminium—TNNC1—lymph node—melanoma	0.0145	0.022	CbGeAlD
Dihydroxyaluminium—Encephalopathy—Carmustine—melanoma	0.0122	0.0356	CcSEcCtD
Dihydroxyaluminium—Lung disorder—Temozolomide—melanoma	0.0107	0.0312	CcSEcCtD
Dihydroxyaluminium—Extravasation—Bleomycin—melanoma	0.0103	0.03	CcSEcCtD
Dihydroxyaluminium—Extravasation—Dactinomycin—melanoma	0.00961	0.028	CcSEcCtD
Dihydroxyaluminium—Extravasation—Carmustine—melanoma	0.009	0.0262	CcSEcCtD
Dihydroxyaluminium—Phlebitis—Bleomycin—melanoma	0.00758	0.0221	CcSEcCtD
Dihydroxyaluminium—Coma—Carmustine—melanoma	0.00717	0.0209	CcSEcCtD
Dihydroxyaluminium—Phlebitis—Dactinomycin—melanoma	0.00707	0.0206	CcSEcCtD
Dihydroxyaluminium—Chills—Vemurafenib—melanoma	0.00669	0.0195	CcSEcCtD
Dihydroxyaluminium—Phlebitis—Carmustine—melanoma	0.00661	0.0193	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Carmustine—melanoma	0.00658	0.0192	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Temozolomide—melanoma	0.00636	0.0185	CcSEcCtD
Dihydroxyaluminium—Back pain—Vemurafenib—melanoma	0.00628	0.0183	CcSEcCtD
Dihydroxyaluminium—Thirst—Temozolomide—melanoma	0.00579	0.0169	CcSEcCtD
Dihydroxyaluminium—Extravasation—Docetaxel—melanoma	0.00578	0.0168	CcSEcCtD
Dihydroxyaluminium—Hyponatraemia—Carmustine—melanoma	0.00572	0.0167	CcSEcCtD
Dihydroxyaluminium—Infection—Vemurafenib—melanoma	0.00526	0.0153	CcSEcCtD
Dihydroxyaluminium—Dehydration—Temozolomide—melanoma	0.00512	0.0149	CcSEcCtD
Dihydroxyaluminium—Hypotension—Vemurafenib—melanoma	0.00495	0.0144	CcSEcCtD
Dihydroxyaluminium—Lightheadedness—Docetaxel—melanoma	0.00451	0.0131	CcSEcCtD
Dihydroxyaluminium—Phlebitis—Docetaxel—melanoma	0.00425	0.0124	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Docetaxel—melanoma	0.00423	0.0123	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Vemurafenib—melanoma	0.00419	0.0122	CcSEcCtD
Dihydroxyaluminium—Chills—Bleomycin—melanoma	0.00405	0.0118	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Vemurafenib—melanoma	0.0039	0.0114	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Docetaxel—melanoma	0.00386	0.0113	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Carmustine—melanoma	0.0038	0.0111	CcSEcCtD
Dihydroxyaluminium—Chills—Dactinomycin—melanoma	0.00378	0.011	CcSEcCtD
Dihydroxyaluminium—Hyponatraemia—Docetaxel—melanoma	0.00368	0.0107	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Temozolomide—melanoma	0.00367	0.0107	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Vemurafenib—melanoma	0.00362	0.0106	CcSEcCtD
Dihydroxyaluminium—Dizziness—Vemurafenib—melanoma	0.0035	0.0102	CcSEcCtD
Dihydroxyaluminium—Chills—Temozolomide—melanoma	0.00342	0.00995	CcSEcCtD
Dihydroxyaluminium—Dehydration—Docetaxel—melanoma	0.00341	0.00992	CcSEcCtD
Dihydroxyaluminium—Vomiting—Vemurafenib—melanoma	0.00337	0.00981	CcSEcCtD
Dihydroxyaluminium—Back pain—Carmustine—melanoma	0.00332	0.00967	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Carmustine—melanoma	0.00323	0.00942	CcSEcCtD
Dihydroxyaluminium—Oedema—Bleomycin—melanoma	0.00321	0.00934	CcSEcCtD
Dihydroxyaluminium—Back pain—Temozolomide—melanoma	0.00321	0.00934	CcSEcCtD
Dihydroxyaluminium—Infection—Bleomycin—melanoma	0.00319	0.00928	CcSEcCtD
Dihydroxyaluminium—Nausea—Vemurafenib—melanoma	0.00315	0.00916	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Temozolomide—melanoma	0.00313	0.0091	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Docetaxel—melanoma	0.00308	0.00898	CcSEcCtD
Dihydroxyaluminium—Hypotension—Bleomycin—melanoma	0.003	0.00873	CcSEcCtD
Dihydroxyaluminium—Oedema—Dactinomycin—melanoma	0.00299	0.00871	CcSEcCtD
Dihydroxyaluminium—Vertigo—Temozolomide—melanoma	0.00298	0.00868	CcSEcCtD
Dihydroxyaluminium—Convulsion—Carmustine—melanoma	0.00297	0.00866	CcSEcCtD
Dihydroxyaluminium—Infection—Dactinomycin—melanoma	0.00297	0.00866	CcSEcCtD
Dihydroxyaluminium—Convulsion—Temozolomide—melanoma	0.00287	0.00837	CcSEcCtD
Dihydroxyaluminium—Oedema—Carmustine—melanoma	0.0028	0.00816	CcSEcCtD
Dihydroxyaluminium—Infection—Carmustine—melanoma	0.00278	0.0081	CcSEcCtD
Dihydroxyaluminium—Pain—Bleomycin—melanoma	0.00274	0.00799	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Carmustine—melanoma	0.00273	0.00796	CcSEcCtD
Dihydroxyaluminium—Oedema—Temozolomide—melanoma	0.00271	0.00788	CcSEcCtD
Dihydroxyaluminium—Infection—Temozolomide—melanoma	0.00269	0.00783	CcSEcCtD
Dihydroxyaluminium—Hypotension—Carmustine—melanoma	0.00262	0.00762	CcSEcCtD
Dihydroxyaluminium—Pain—Dactinomycin—melanoma	0.00256	0.00745	CcSEcCtD
Dihydroxyaluminium—Urticaria—Bleomycin—melanoma	0.00255	0.00742	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Docetaxel—melanoma	0.00254	0.0074	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Bleomycin—melanoma	0.00254	0.00739	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Docetaxel—melanoma	0.00244	0.00711	CcSEcCtD
Dihydroxyaluminium—Pain—Carmustine—melanoma	0.0024	0.00697	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Dactinomycin—melanoma	0.00237	0.00689	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Bleomycin—melanoma	0.00236	0.00688	CcSEcCtD
Dihydroxyaluminium—Pain—Temozolomide—melanoma	0.00231	0.00674	CcSEcCtD
Dihydroxyaluminium—Chills—Docetaxel—melanoma	0.00227	0.00662	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Carmustine—melanoma	0.00221	0.00645	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Dactinomycin—melanoma	0.0022	0.00642	CcSEcCtD
Dihydroxyaluminium—Urticaria—Temozolomide—melanoma	0.00215	0.00626	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Temozolomide—melanoma	0.00214	0.00623	CcSEcCtD
Dihydroxyaluminium—Back pain—Docetaxel—melanoma	0.00213	0.00621	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Carmustine—melanoma	0.00206	0.00601	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Dactinomycin—melanoma	0.00205	0.00596	CcSEcCtD
Dihydroxyaluminium—Vomiting—Bleomycin—melanoma	0.00204	0.00594	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Temozolomide—melanoma	0.00199	0.00581	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Carmustine—melanoma	0.00192	0.00558	CcSEcCtD
Dihydroxyaluminium—Convulsion—Docetaxel—melanoma	0.00191	0.00556	CcSEcCtD
Dihydroxyaluminium—Nausea—Bleomycin—melanoma	0.00191	0.00555	CcSEcCtD
Dihydroxyaluminium—Vomiting—Dactinomycin—melanoma	0.0019	0.00554	CcSEcCtD
Dihydroxyaluminium—Dizziness—Carmustine—melanoma	0.00185	0.00539	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Temozolomide—melanoma	0.00185	0.00539	CcSEcCtD
Dihydroxyaluminium—Oedema—Docetaxel—melanoma	0.0018	0.00524	CcSEcCtD
Dihydroxyaluminium—Dizziness—Temozolomide—melanoma	0.00179	0.00521	CcSEcCtD
Dihydroxyaluminium—Infection—Docetaxel—melanoma	0.00179	0.00521	CcSEcCtD
Dihydroxyaluminium—Vomiting—Carmustine—melanoma	0.00178	0.00519	CcSEcCtD
Dihydroxyaluminium—Nausea—Dactinomycin—melanoma	0.00178	0.00518	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Docetaxel—melanoma	0.00176	0.00512	CcSEcCtD
Dihydroxyaluminium—Vomiting—Temozolomide—melanoma	0.00172	0.00501	CcSEcCtD
Dihydroxyaluminium—Hypotension—Docetaxel—melanoma	0.00168	0.0049	CcSEcCtD
Dihydroxyaluminium—Nausea—Carmustine—melanoma	0.00166	0.00484	CcSEcCtD
Dihydroxyaluminium—Nausea—Temozolomide—melanoma	0.00161	0.00468	CcSEcCtD
Dihydroxyaluminium—Pain—Docetaxel—melanoma	0.00154	0.00448	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Docetaxel—melanoma	0.00142	0.00414	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Docetaxel—melanoma	0.00133	0.00386	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Docetaxel—melanoma	0.00123	0.00359	CcSEcCtD
Dihydroxyaluminium—Dizziness—Docetaxel—melanoma	0.00119	0.00347	CcSEcCtD
Dihydroxyaluminium—Vomiting—Docetaxel—melanoma	0.00114	0.00333	CcSEcCtD
Dihydroxyaluminium—Nausea—Docetaxel—melanoma	0.00107	0.00311	CcSEcCtD
